ESC Cardio Talk

Swiss researchers Christoph Grani & Katja Odening discuss the assessment of risk stratification in hypertrophic cardiomyopathy (HCM) and the influence of genetics. They explore the role of genetic testing and late gadolinium enhancement (LGE) in diagnosing and visualizing fibrosis in HCM. The podcast also explores different approaches to quantifying LGE, the potential of AI-based segmentation, and the use of artificial intelligence for risk stratification and better patient outcomes.

With Trudy Pang & Richard Verrier, Beth Israel Deaconess Medical Center, Boston - USA. Link to paper Link to editorial

With Paul Leeson & Winok Lapidaire, University of Oxford - UK Link to editorial Link to paper

With Johann Bauersachs & Samira Soltani, Hannover Medical School, Hannover - Germany. Link to paper Link to editorial

With Gregg Pressman & Christian Witzke-Sanz, Thomas Jefferson University, Philadelphia - USA Link to paper Link editorial

With Luc Pierard, University of Liège, Liège - Belgium & Bernard Cosyns, University of Brussels, Brussels - Belgium Link to editorial Link to paper

Gregory Marcus and Chris Wong, both from the University of California, discuss the development of the Harm to AF Lifestyle Risk Score and the importance of accurate prediction scores for atrial fibrillation. They explore lifestyle factors, such as diabetes and physical activity, that contribute to predicting AFib. The limitations of the study, including self-reporting of lifestyle factors, are discussed. The benefits and ease of use of the HARMS2-AF score in predicting AFib are highlighted.

With Otto Smiseth & Lars-Egil Hammersboen, University of Oslo, Oslo - Norway Link to paper Link to editorial

With Tommaso Gori, University Medical Center of Mainz, Mainz - Germany & Margaret McEntegart, Columbia University Medical Center, New York - USA. Link to paper Link to editorial

With Artur Fedorowski & Marcus Stahlberg, Karolinska Institute, Stockholm - Sweden. Link to paper Link to editorial